Litigation Details for Baudax Bio, Inc. v. Axsome Therapeutics, Inc. (D. Del. 2021)
✉ Email this page to a colleague
Baudax Bio, Inc. v. Axsome Therapeutics, Inc. (D. Del. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-11-09 |
| Court | District Court, D. Delaware | Date Terminated | 2022-02-08 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Parties | BAUDAX BIO, INC. | ||
| Patents | 10,463,673; 10,471,067; 8,512,727; 9,974,746 | ||
| Attorneys | James Harry Stone Levine | ||
| Firms | Troutman Pepper Hamilton Sanders, LLP, Trial and Dispute Resolution, Hercules Plaza | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Baudax Bio, Inc. v. Axsome Therapeutics, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Baudax Bio, Inc. v. Axsome Therapeutics, Inc. (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-11-09 | 1 | Complaint | Opinion that Each Claim of U.S. Patent Nos. 8,512,727; 9,974,746; 10,463,673; and 10,471,067 is Invalid, …owns by assignment U.S. Patent No. 8,512,727 (the “’727 Patent”). The ’727 Patent was issued on August …the “’067 Patent”). The ’067 Patent was issued on November 12, 2019. The ’067 Patent is valid and legally… 19. The ’727 Patent and the ’067 Patent, among other patents, are listed in the FDA’s Approved… -6- 120649365 ’727 Patent, the ’067 Patent, and certain other patents listed in the Orange Book | External link to document |
| 2021-11-09 | 3 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,512,727; US 10,471,067. (twk) (Entered…2021 8 February 2022 1:21-cv-01585 830 Patent None District Court, D. Delaware | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
